Loading clinical trials...
Loading clinical trials...
Early Nutrition and Neurological Development of Very Preterm Infants
The main goal of this study is to determine, in preterm infants born with a GA \< 32 weeks, the association between: * the quantity of mother's milk and duration and breastfeeding * the intake of polyunsaturated fatty acids and iron during hospitalizations
The main hypothesis of this study is that the intake of lipid during hospitalization in neonatology department is associated with neurological development of preterm infants born with a GA \< 32 weeks. The other hypotheses are that iron intake and the duration of breastfeeding are also associated with the development of preterm infants. In the previous study EPINUTRI (NCT01486173), the development of infants was evaluated until the age of 1 year. EPINUTRI\_3 is the follow-up of EPINUTRI until the age of 3 years. The aim of EPINUTRI\_3 study is to determine the association between lipid intake during hospitalization in neonatology department of preterm infants born with a GA \< 32 weeks. The secondary objective is : \- to evaluate the association between these factors and communication, developmental and social-emotional delays with the test " Ages and Stages questionnaire " (ASQ) at 3 years of age.
Age
3 - 3 years
Sex
ALL
Healthy Volunteers
No
Hôpital Necker Assistance Publique- Hôpitaux de Paris
Paris, France
Start Date
July 1, 2014
Primary Completion Date
July 1, 2015
Completion Date
December 31, 2017
Last Updated
November 20, 2025
206
ACTUAL participants
Premature infants with a GA < 32 weeks
OTHER
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
NCT07410858
NCT07322731
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions